These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 16716347)

  • 1. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
    Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
    Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP-inhibitor treatment prevents hypertension induced cardiac remodeling by favorable modulation of heat shock proteins, Akt-1/GSK-3β and several PKC isoforms.
    Deres L; Bartha E; Palfi A; Eros K; Riba A; Lantos J; Kalai T; Hideg K; Sumegi B; Gallyas F; Toth K; Halmosi R
    PLoS One; 2014; 9(7):e102148. PubMed ID: 25014216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of L-2286, a poly(ADP-ribose)polymerase inhibitor and enalapril on myocardial remodeling and heart failure.
    Bartha E; Kiss GN; Kalman E; Kulcsár G; Kálai T; Hideg K; Habon T; Sumegi B; Toth K; Halmosi R
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):253-61. PubMed ID: 18806606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
    Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
    J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
    Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
    Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
    Hardt SE; Tomita H; Katus HA; Sadoshima J
    Circ Res; 2004 Apr; 94(7):926-35. PubMed ID: 15001529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats.
    Magyar K; Deres L; Eros K; Bruszt K; Seress L; Hamar J; Hideg K; Balogh A; Gallyas F; Sumegi B; Toth K; Halmosi R
    Biochim Biophys Acta; 2014 Jul; 1842(7):935-44. PubMed ID: 24657811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of kinase cascade activation and heat shock protein expression by poly(ADP-ribose) polymerase inhibition in doxorubicin-induced heart failure.
    Bartha E; Solti I; Szabo A; Olah G; Magyar K; Szabados E; Kalai T; Hideg K; Toth K; Gero D; Szabo C; Sumegi B; Halmosi R
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):380-91. PubMed ID: 21697725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibition and postinfarction myocardial remodeling.
    Halmosi R; Deres L; Gal R; Eros K; Sumegi B; Toth K
    Int J Cardiol; 2016 Aug; 217 Suppl():S52-9. PubMed ID: 27392900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B; Johnson JN; Ross RS; Singh M; Singh K
    J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel.
    Terashima Y; Sato T; Yano T; Maas O; Itoh T; Miki T; Tanno M; Kuno A; Shimamoto K; Miura T
    J Mol Cell Cardiol; 2010 Nov; 49(5):762-70. PubMed ID: 20692265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
    Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
    J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons.
    Gil C; Chaib-Oukadour I; Aguilera J
    Biochem J; 2003 Jul; 373(Pt 2):613-20. PubMed ID: 12710887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
    Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
    Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK-3beta and oxidative stress in aged brain. Role of poly(ADP- -ribose) polymerase-1.
    Songin M; Jeśko H; Czapski G; Adamczyk A; Strosznajder RP
    Folia Neuropathol; 2007; 45(4):220-9. PubMed ID: 18176896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-AIQ inhibits H2O2-induced apoptosis through reactive oxygen species scavenging and Akt/GSK-3β signaling pathway in H9c2 cardiomyocytes.
    Park ES; Kang JC; Kang DH; Jang YC; Yi KY; Chung HJ; Park JS; Kim B; Feng ZP; Shin HS
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):90-8. PubMed ID: 23352507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways.
    Gao X; Zhang H; Takahashi T; Hsieh J; Liao J; Steinberg GK; Zhao H
    J Neurochem; 2008 May; 105(3):943-55. PubMed ID: 18182053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.